AU2001239549A1 - Keratinocyte growth inhibitors and hydroxamic acid derivatives - Google Patents
Keratinocyte growth inhibitors and hydroxamic acid derivativesInfo
- Publication number
- AU2001239549A1 AU2001239549A1 AU2001239549A AU3954901A AU2001239549A1 AU 2001239549 A1 AU2001239549 A1 AU 2001239549A1 AU 2001239549 A AU2001239549 A AU 2001239549A AU 3954901 A AU3954901 A AU 3954901A AU 2001239549 A1 AU2001239549 A1 AU 2001239549A1
- Authority
- AU
- Australia
- Prior art keywords
- acid derivatives
- hydroxamic acid
- growth inhibitors
- keratinocyte growth
- keratinocyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/62—Isoquinoline or hydrogenated isoquinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000084126 | 2000-03-24 | ||
| JP2000-84126 | 2000-03-24 | ||
| JP2000-120430 | 2000-04-21 | ||
| JP2000120430 | 2000-04-21 | ||
| JP2000394983 | 2000-12-26 | ||
| JP2000-394983 | 2000-12-26 | ||
| PCT/JP2001/002251 WO2001070269A1 (en) | 2000-03-24 | 2001-03-22 | Keratinocyte growth inhibitors and hydroxamic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001239549A1 true AU2001239549A1 (en) | 2001-10-03 |
Family
ID=27342786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001239549A Abandoned AU2001239549A1 (en) | 2000-03-24 | 2001-03-22 | Keratinocyte growth inhibitors and hydroxamic acid derivatives |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20030229113A1 (en) |
| AU (1) | AU2001239549A1 (en) |
| WO (1) | WO2001070269A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2388475C (en) | 2002-05-31 | 2009-12-08 | Brantford Chemicals Inc. | Preparation of chiral 1,2,3,4-tetrahydro-6,7-dialkoxy-3-isoquinolinecarboxylic acid and derivatives |
| MXPA04012932A (en) * | 2002-06-26 | 2005-06-03 | Japan Bioindustry Ass | Novel azasugar derivative and drug containing the same as the active ingredient. |
| EP1574856A4 (en) | 2002-12-20 | 2007-09-05 | Shigeki Higashiyama | Method of screening cell growth inhibitor and cell growth inhibitor |
| NZ587207A (en) | 2008-02-01 | 2012-05-25 | Takeda Pharmaceutical | Oxim derivatives as hsp90 inhibitors |
| CN104870422B (en) | 2012-10-31 | 2019-03-15 | 富士胶片富山化学株式会社 | Amine derivatives or their salts |
| EP2996709B1 (en) | 2013-05-15 | 2020-05-06 | The Board of Trustees of the Leland Stanford Junior University | Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing |
| JO3466B1 (en) | 2013-12-20 | 2020-07-05 | Takeda Pharmaceuticals Co | Tetrahydropyridopyrazines modulators of gpr6 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
| ATE187455T1 (en) * | 1990-08-14 | 1999-12-15 | Chugai Pharmaceutical Co Ltd | METHOTREXATE DERIVATIVES WITH ANTIRHEUMATIC ACTIVITY |
| CA2200163A1 (en) * | 1996-03-22 | 1997-09-22 | Michael Robert Wiley | Antithrombotic diamides |
| US5962481A (en) * | 1996-10-16 | 1999-10-05 | American Cyanamid Company | Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| US6506798B1 (en) * | 1997-07-01 | 2003-01-14 | Warner-Lambert Company | 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors |
| US6277885B1 (en) * | 1999-01-27 | 2001-08-21 | American Cyanamid Company | Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors |
| US20030091568A1 (en) * | 2000-04-07 | 2003-05-15 | Jurgen Frey | Inhibitors for the formation of soluble human CD23 |
-
2001
- 2001-03-22 AU AU2001239549A patent/AU2001239549A1/en not_active Abandoned
- 2001-03-22 WO PCT/JP2001/002251 patent/WO2001070269A1/en not_active Ceased
- 2001-03-22 US US10/239,675 patent/US20030229113A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001070269A1 (en) | 2001-09-27 |
| US20030229113A1 (en) | 2003-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001258771A1 (en) | -secretase inhibitors | |
| AU2002227122A1 (en) | Systems and methods for management of memory | |
| AU2001244399A1 (en) | Gamma-secretase inhibitors | |
| AU2001244355A1 (en) | Heterobiarylsulphonamides and their use as pde 7 inhibitors | |
| AU4201799A (en) | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors | |
| AU3312100A (en) | Hydroxamic and carboxylic acid derivatives | |
| AU5991699A (en) | Quinolizinones as integrin inhibitors | |
| AU7079700A (en) | Improved stable formulations of ace inhibitors, and methods for preparation thereof | |
| AU5634999A (en) | Hydroxamic acid derivatives as proteinase inhibitors | |
| AU2001255199A1 (en) | Ceramide derivatives and method of use | |
| AU2001233034A1 (en) | Method for preparing alpha-sulfonyl hydroxamic acid derivatives | |
| AU2001236052A1 (en) | Urease inhibitors | |
| AU2002211662A1 (en) | Nf-kappab inhibitors | |
| AU2001244596A1 (en) | Indolylpyrrole derivatives and cell death inhibitors | |
| AU4933000A (en) | Hydroxamic and carboxylic acid derivatives | |
| AU5213300A (en) | 2-nh-pyridones and pyrimidones as mrs inhibitors | |
| AU2001281799A1 (en) | Benzamide derivatives and their use as apob-100 and mtp inhibitors | |
| AU2001267416A1 (en) | N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23 | |
| AU2001239549A1 (en) | Keratinocyte growth inhibitors and hydroxamic acid derivatives | |
| AU2002216223A1 (en) | Preservation of cells | |
| AU5690099A (en) | Free radical inhibitors for quenching aqueous phase polymer growth and related methods | |
| AU2002214038A1 (en) | Inhibitors of transglutaminases | |
| AU2002239438A1 (en) | 2,4-hexadienoic acid and derivatives as corrosion inhibitors | |
| AU2001236718A1 (en) | Bioreactor and related method | |
| AU6992500A (en) | Alphavbeta3 integrin inhibitors |